Novo Nordisk extends research collaboration with UK drug discovery firm
Novo Nordisk and e-therapeutics will use the latter’s genomics technology platform to analyse data from diabetes patients.
Novo Nordisk and e-therapeutics will use the latter’s genomics technology platform to analyse data from diabetes patients.
Research shows how cell and gene therapy companies are driven to success despite the talent pool in management still being quite shallow.